229 related articles for article (PubMed ID: 15606400)
1. Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects.
Gardner JD; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1373-9. PubMed ID: 15606400
[TBL] [Abstract][Full Text] [Related]
2. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.
Gardner JD; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1381-6. PubMed ID: 15606401
[TBL] [Abstract][Full Text] [Related]
3. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects.
Zerbib F; des Varannes SB; Roman S; Pouderoux P; Artigue F; Chaput U; Mion F; Caillol F; Verin E; Bommelaer G; Ducrotté P; Galmiche JP; Sifrim D
Aliment Pharmacol Ther; 2005 Nov; 22(10):1011-21. PubMed ID: 16268977
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects.
Bredenoord AJ; Smout AJ
Aliment Pharmacol Ther; 2005 Apr; 21(7):917; author reply 918. PubMed ID: 15801927
[No Abstract] [Full Text] [Related]
5. The fractal nature of human gastro-oesophageal reflux.
Gardner JD; Young W; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2005 Nov; 22(9):823-30. PubMed ID: 16225491
[TBL] [Abstract][Full Text] [Related]
6. Postprandial oesophageal integrated acidity is a reliable predictor of gastro-oesophageal reflux disease.
Shih GL; Brensinger CM; Katzka DA; Metz DC
Aliment Pharmacol Ther; 2005 Jun; 21(12):1475-82. PubMed ID: 15948815
[TBL] [Abstract][Full Text] [Related]
7. Use of 24-hour oesophageal pH-metry for the detection of gastro-oesophageal reflux in infants: what is the ideal score and the optimal threshold? A receiver-operating-characteristic analysis.
Carroccio A; Cavataio F; Acierno E; Montalto G; Lorello D; Tumminello M; Soresi M; Li Voti G; Iacono G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):297-302. PubMed ID: 9476179
[TBL] [Abstract][Full Text] [Related]
8. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
9. Gastro-oesophageal acid reflux and sphincter pressure in normal human subjects.
Boesby S
Scand J Gastroenterol; 1975; 10(7):731-6. PubMed ID: 242072
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory 24-hour oesophageal pH monitoring in normal subjects: a multicentre study in Italy. G.I.S.M.A.D. GOR Study Group.
Baldi F; Ferrarini F; Longanesi A; Bersani G
Ital J Gastroenterol; 1991 Nov; 23(8):477-80. PubMed ID: 1751822
[TBL] [Abstract][Full Text] [Related]
12. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
13. [Ischemic heart disease and gastro-oesophageal reflux disease--simultaneous 24 monitoring of ECG and oesophageal pH].
Dobrzycki S; Baniukiewicz A; Musiał WJ; Skrodzka D; Zaremba-Woroniecka A; Korecki J; Łaszewicz W; Kralisz P; Paruk J; Kochman W
Przegl Lek; 2002; 59(9):675-7. PubMed ID: 12632883
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the mechanism of gastro-oesophageal reflux and oesophageal acid exposure in patients with reflux disease.
Scheffer RC; Wassenaar EB; Herwaarden MA; Holloway RH; Samsom M; Smout AJ; Akkermans LM
Neurogastroenterol Motil; 2005 Oct; 17(5):654-62. PubMed ID: 16185303
[TBL] [Abstract][Full Text] [Related]
15. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
Frazzoni M; De Micheli E; Zentilin P; Savarino V
Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174
[TBL] [Abstract][Full Text] [Related]
17. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.
Katz PO
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265
[TBL] [Abstract][Full Text] [Related]
18. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of gastro-oesophageal reflux and oesophagocardiac reflex in patients with angina-like chest pain following cardiologic investigations.
Rosztóczy A; Vass A; Izbéki F; Nemes A; Rudas L; Csanády M; Lonovics J; Forster T; Wittmann T
Int J Cardiol; 2007 May; 118(1):62-8. PubMed ID: 16891012
[TBL] [Abstract][Full Text] [Related]
20. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
Roman S; Serraj I; Damon H; Mion F
Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
